On July 12, the Global Alliance for Vaccines and Immunization announced that China National Pharmaceutical Group and Kexing Biotechnology have signed a cooperation agreement with the "New Coronary Pneumonia Vaccine Implementation Plan". The two companies will provide 110 million doses of vaccine to the plan by October this year. To prevent and control the epidemic in developing countries.
At present, China has provided 500 million doses of new crown vaccines and stock solutions to the world, equivalent to one-sixth of the current global total output of new crown vaccines.
The data picture shows the staff packing and weighing the vaccine in the production workshop of Beijing Kexing Zhongwei Biotechnology Co., Ltd. on May 11, Daxing, Beijing.
Photo by China News Agency reporter Jiang Qiming
Release time: 2021-07-12 22:31:34 【Editor: Li Jun】